UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In situ aromatization enhances breast tumor estradiol levels and cellular proliferation

Cancer research (Chicago, Ill.), 1998-03, Vol.58 (5), p.927-932

1998

Volltextzugriff (PDF)

Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production

Cancer research (Chicago, Ill.), 2015-03, Vol.75 (6), p.996-1008

2015

Volltextzugriff (PDF)

Obesity Induces Temporally Regulated Alterations in the Extracellular Matrix That Drive Breast Tumor Invasion and Metastasis

Cancer research (Chicago, Ill.), 2024-09, Vol.84 (17), p.2761-2775

2024

Volltextzugriff (PDF)

Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13), p.3192-3204

2019

Volltextzugriff (PDF)

A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4112-4115

2009

Volltextzugriff (PDF)

Inhibition of apoptosis during development of colorectal cancer

Cancer research (Chicago, Ill.), 1995-05, Vol.55 (9), p.1811-1816

1995

Volltextzugriff (PDF)

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

Cancer research (Chicago, Ill.), 1998-11, Vol.58 (22), p.5248-5257

1998

Volltextzugriff (PDF)

The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance : Correlation with replicative bypass of platinum-DNA adducts

Cancer research (Chicago, Ill.), 1998-08, Vol.58 (16), p.3579-3585

1998

Volltextzugriff (PDF)

Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (13), p.4394-4399

2004

Volltextzugriff (PDF)

Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas

Cancer research (Chicago, Ill.), 2019-08, Vol.79 (16), p.4026-4041

2019

Volltextzugriff (PDF)

Abstract OT3-03-01: Open-label, single-arm study evaluating the antitumor activity and safety of niraparib as neoadjuvant treatment in patients with localized, HER2 -negative, BRCA -mutant breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT3-03-01-OT3-03-01

2019

Volltextzugriff (PDF)

Molecular detection of genetic alterations in the serum of colorectal cancer patients

Cancer research (Chicago, Ill.), 1998-04, Vol.58 (7), p.1405-1407

1998

Volltextzugriff (PDF)

Abstract LB-391: Combination of insulin-like growth factor-1 receptor/insulin receptor (IGF1R/IR) antagonist with anti-PD-L1 antibody blocks triple-negative breast cancer (TNBC) progression

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.LB-391-LB-391

2020

Volltextzugriff (PDF)

Abstract P5-11-01: Phamacodynamic and circulating tumor DNA evaluation in a phase I study of GDC-0927, a selective estrogen receptor antagonist/ degrader (SERD)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-11-01

2019

Volltextzugriff (PDF)

Abstract 1012: Selective estrogen receptor downregulators and immune checkpoint inhibitors in breast cancer immunotherapy

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1012-1012

2019

Volltextzugriff (PDF)

Abstract 692: Discovery of novel metformin derivatives with potent antitumor activity in combination with immunotherapy for treatment of triple-negative breast cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.692-692

2020

Volltextzugriff (PDF)

Identification of two candidate tumor suppressor genes on chromosome 17p13.3

Cancer research (Chicago, Ill.), 1996-05, Vol.56 (9), p.1997-2002

1996

Volltextzugriff (PDF)

AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells

Cancer research (Chicago, Ill.), 1998-07, Vol.58 (14), p.2973-2977

1998

Volltextzugriff (PDF)

Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5666-5666

2020

Volltextzugriff (PDF)

Abstract P5-13-21: Relationship between circulating tumor DNA and response to neoadjuvant niraparib in HER2-negative, BRCA-mutated breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-13-21

2022

Volltextzugriff (PDF)

Abstract OT3-02-01: Development of cell-free nucleic acid-based tests for early detection of breast cancer: The STRIVE study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT3-02-01-OT3-02-01

2018

Volltextzugriff (PDF)

Abstract P6-07-03: Broken promise of liquid biopsy: Plasma DNA does not accurately reflect tumor DNA in metastatic breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-07-03

2017

Volltextzugriff (PDF)

Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines

Cancer research (Chicago, Ill.), 1997-03, Vol.57 (5), p.850-856

1997

Volltextzugriff (PDF)

Abstract OT1-02-02: A phase 1, first-in-human, multi-part study of RAD140, an oral nonsteroidal selective androgen receptor modulator, in postmenopausal women with hormone receptor positive breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-02-02-OT1-02-02

2019

Volltextzugriff (PDF)

Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis

Cancer research (Chicago, Ill.), 1998-04, Vol.58 (8), p.1750-1753

1998

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

KollektionPROLA

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(102)

Sprache

Englisch
(102)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(42)
Oncology
(42)
Science & Technology
(42)
Biological And Medical Sciences
(40)
Humans
(40)
Medical Sciences
(39)
Female
(32)
Antineoplastic Agents
(23)
Pharmacology. Drug Treatments
(23)
Animals
(18)
Tumors
(17)
Mice
(13)
General Aspects
(11)
Tumor Cells, Cultured
(10)
Cell Line
(9)
Chemotherapy
(9)
Ovarian Neoplasms - Pathology
(8)
Cisplatin - Pharmacology
(7)
Drug Resistance
(7)
Gastroenterology. Liver. Pancreas. Abdomen
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

In situ aromatization enhances breast tumor estradiol levels and cellular proliferation

Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production

Obesity Induces Temporally Regulated Alterations in the Extracellular Matrix That Drive Breast Tumor Invasion and Metastasis

Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants

A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus

Inhibition of apoptosis during development of colorectal cancer

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance : Correlation with replicative bypass of platinum-DNA adducts

Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt

Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas

Abstract OT3-03-01: Open-label, single-arm study evaluating the antitumor activity and safety of niraparib as neoadjuvant treatment in patients with localized, HER2 -negative, BRCA -mutant breast cancer

Molecular detection of genetic alterations in the serum of colorectal cancer patients

Abstract LB-391: Combination of insulin-like growth factor-1 receptor/insulin receptor (IGF1R/IR) antagonist with anti-PD-L1 antibody blocks triple-negative breast cancer (TNBC) progression

Abstract P5-11-01: Phamacodynamic and circulating tumor DNA evaluation in a phase I study of GDC-0927, a selective estrogen receptor antagonist/ degrader (SERD)

Abstract 1012: Selective estrogen receptor downregulators and immune checkpoint inhibitors in breast cancer immunotherapy

Abstract 692: Discovery of novel metformin derivatives with potent antitumor activity in combination with immunotherapy for treatment of triple-negative breast cancer

Identification of two candidate tumor suppressor genes on chromosome 17p13.3

AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells

Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer

Abstract P5-13-21: Relationship between circulating tumor DNA and response to neoadjuvant niraparib in HER2-negative, BRCA-mutated breast cancer

Abstract OT3-02-01: Development of cell-free nucleic acid-based tests for early detection of breast cancer: The STRIVE study

Abstract P6-07-03: Broken promise of liquid biopsy: Plasma DNA does not accurately reflect tumor DNA in metastatic breast cancer

Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines

Abstract OT1-02-02: A phase 1, first-in-human, multi-part study of RAD140, an oral nonsteroidal selective androgen receptor modulator, in postmenopausal women with hormone receptor positive breast cancer

Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis

Aktive Filter

Suchergebnisse filtern